Revisiting policy on chronic HCV treatment under the Thai Universal Health Coverage: An economic evaluation and budget impact analysis-Reference-Cited by-同舟云学术

Revisiting policy on chronic HCV treatment under the Thai Universal Health Coverage: An economic evaluation and budget impact analysis

Published:2018-02-21 Issue:2 Volume:13 Page:e0193112
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Rattanavipapong Waranya^ORCID,Anothaisintawee Thunyarat,Teerawattananon Yot

Funder

Thailand Research Fund

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference49 articles.

1. Global health sector strategy on viral hepatitis, 2016–2021,2016

2. Berger S. Infectious Diseases of Thailand: 2017 GIDEON Informatics2017.

3. Global distribution and prevalence of hepatitis C virus genotypes;JP Messina;Hepatology (Baltimore, Md),2015

4. The natural history of hepatitis C virus (HCV) infection;SL Chen;International journal of medical sciences,2006

5. World Health Organization. 20th Expert Committee on the Selection and Use of Essential Medicines Geneva2015 [cited 2016 29th December]. http://www.who.int/selection_medicines/committees/expert/20/en/.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential impact of the Comprehensive and Progressive Agreement for Trans-Pacific Partnership on Thailand’s hepatitis C treatment program;Globalization and Health;2024-06-13

2. Simplified Test-to-Treat Strategy for Hepatitis C in Thailand: The Phetchabun Model;The Journal of Infectious Diseases;2023-09-13

3. An amino acid substitution in HCV core antigen limits its use as a reliable measure of HCV infection compared with HCV RNA;PLOS ONE;2023-06-29

4. Knowledge, attitude, and behaviors toward liver health and viral hepatitis-related liver diseases in Thailand;Medicine;2021-12-23

5. Global hepatitis C elimination: an investment framework;The Lancet Gastroenterology & Hepatology;2020-10